Literature DB >> 12827408

Increased expression of nuclear factor-kappaB/RelA is correlated with tumor angiogenesis in human colorectal cancer.

Hong-Gang Yu1, Xia Zhong, Yan-Ning Yang, He-Sheng Luo, Jie-Ping Yu, Juris J Meier, Henning Schrader, Andreas Bastian, Wolfgang E Schmidt, Frank Schmitz.   

Abstract

BACKGROUND AND AIMS: Recent studies have shown that nuclear factor-kappa B/RelA (NF-kappa B/RelA) is involved in tumor angiogenesis. This study examined whether NF-kappa B/RelA expression is associated with vascular endothelial growth factor (VEGF) expression and microvessel density in human colorectal cancer.
MATERIALS AND METHODS: Ten specimens from normal colorectal mucosa and 52 colorectal adenocarcinomas were obtained by surgery or endoscopy. Immunohistochemical expression of NF-kappa B/RelA, VEGF, and CD34 was detected on paraffin-embedded tissue sections.
RESULTS: NF-kappa B/RelA and VEGF were significantly overexpressed and associated with microvessel density in colorectal cancer. A significant association was found between NF-kappa B/RelA and VEGF expression. Clinicopathological features were not correlated with NF-kappa B/RelA, VEGF expression, or microvessel density.
CONCLUSION: Our results suggest that increased expression of NF-kappa B/RelA contributes to tumor angiogenesis in colorectal cancer. VEGF may play an important role in mediating the NF-kappa B/RelA angiogenic pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12827408     DOI: 10.1007/s00384-003-0494-z

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  18 in total

1.  What is the evidence that tumors are angiogenesis dependent?

Authors:  J Folkman
Journal:  J Natl Cancer Inst       Date:  1990-01-03       Impact factor: 13.506

Review 2.  Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.

Authors:  L A Liotta; P S Steeg; W G Stetler-Stevenson
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

3.  Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal cancers.

Authors:  S Nakata; K Ito; M Fujimori; K Shingu; S Kajikawa; W Adachi; I Matsuyama; S Tsuchiya; M Kuwano; J Amano
Journal:  Int J Cancer       Date:  1998-04-17       Impact factor: 7.396

Review 4.  The NF-kappa B and I kappa B proteins: new discoveries and insights.

Authors:  A S Baldwin
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

5.  Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis.

Authors:  S M Kang; K Maeda; N Onoda; Y S Chung; B Nakata; Y Nishiguchi; M Sowa
Journal:  Int J Cancer       Date:  1997-10-21       Impact factor: 7.396

6.  Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8.

Authors:  S Huang; J B Robinson; A Deguzman; C D Bucana; I J Fidler
Journal:  Cancer Res       Date:  2000-10-01       Impact factor: 12.701

7.  Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines.

Authors:  S Miyamoto; P J Chiao; I M Verma
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

8.  Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer.

Authors:  Y Takahashi; Y Kitadai; C D Bucana; K R Cleary; L M Ellis
Journal:  Cancer Res       Date:  1995-09-15       Impact factor: 12.701

9.  Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells.

Authors:  S J Mandriota; G Seghezzi; J D Vassalli; N Ferrara; S Wasi; R Mazzieri; P Mignatti; M S Pepper
Journal:  J Biol Chem       Date:  1995-04-28       Impact factor: 5.157

10.  The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.

Authors:  W Wang; J L Abbruzzese; D B Evans; L Larry; K R Cleary; P J Chiao
Journal:  Clin Cancer Res       Date:  1999-01       Impact factor: 12.531

View more
  17 in total

1.  Effects of moderate alcohol consumption on gene expression related to colonic inflammation and antioxidant enzymes in rats.

Authors:  DawnKylee S Klarich; Jerrold Penprase; Patricia Cintora; Octavio Medrano; Danielle Erwin; Susan M Brasser; Mee Young Hong
Journal:  Alcohol       Date:  2017-04-18       Impact factor: 2.405

2.  VEGFR2 translocates to the nucleus to regulate its own transcription.

Authors:  Inês Domingues; José Rino; Jeroen A A Demmers; Primal de Lanerolle; Susana Constantino Rosa Santos
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

3.  Proangiogenic stimulation of bone marrow endothelium engages mTOR and is inhibited by simultaneous blockade of mTOR and NF-kappaB.

Authors:  Lara F Costa; Mercedes Balcells; Elazer R Edelman; Lee M Nadler; Angelo A Cardoso
Journal:  Blood       Date:  2005-09-01       Impact factor: 22.113

4.  Prognostic value of c-FLIPL/s, HIF-1α, and NF-κβ in stage II and III rectal cancer.

Authors:  Anna Novell; Montserrat Martínez-Alonso; Moises Mira; Jordi Tarragona; Antonieta Salud; Xavier Matias-Guiu
Journal:  Virchows Arch       Date:  2014-04-08       Impact factor: 4.064

5.  A microRNA 221- and 222-mediated feedback loop maintains constitutive activation of NFκB and STAT3 in colorectal cancer cells.

Authors:  Sanhong Liu; Xiaohua Sun; Mingliang Wang; Yingyong Hou; Yu Zhan; Yuhang Jiang; Zhanjie Liu; Xinwei Cao; Pengfei Chen; Zhi Liu; Xi Chen; Yu Tao; Chen Xu; Jie Mao; Chunyan Cheng; Cuifeng Li; Yiming Hu; Lunshan Wang; Y Eugene Chin; Yufang Shi; Ulrich Siebenlist; Xiaoren Zhang
Journal:  Gastroenterology       Date:  2014-06-12       Impact factor: 22.682

6.  Nimbolide, a limonoid triterpene, inhibits growth of human colorectal cancer xenografts by suppressing the proinflammatory microenvironment.

Authors:  Subash C Gupta; Sahdeo Prasad; Dhanya R Sethumadhavan; Mangalam S Nair; Yin-Yuan Mo; Bharat B Aggarwal
Journal:  Clin Cancer Res       Date:  2013-06-13       Impact factor: 12.531

7.  Dissociated invasively growing cancer cells with NF-kappaB/p65 positivity after radiotherapy: a new marker for worse clinical outcome in rectal cancer? Preliminary data.

Authors:  Rene Voboril; Jana Voborilova; Vlasta Rychterova; Tomas Jirasek; Josef Dvorak
Journal:  Clin Exp Metastasis       Date:  2008-03-07       Impact factor: 5.150

8.  Anticancer effects of bifidobacteria on colon cancer cell lines.

Authors:  Zeinab Faghfoori; Mohammad Hasan Faghfoori; Amir Saber; Azimeh Izadi; Ahmad Yari Khosroushahi
Journal:  Cancer Cell Int       Date:  2021-05-12       Impact factor: 5.722

9.  Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 2.

Authors:  S M Sagar; D Yance; R K Wong
Journal:  Curr Oncol       Date:  2006-06       Impact factor: 3.677

10.  Pharmacological targeting of NF-kappaB potentiates the effect of the topoisomerase inhibitor CPT-11 on colon cancer cells.

Authors:  P Lagadec; E Griessinger; M P Nawrot; N Fenouille; P Colosetti; V Imbert; M Mari; P Hofman; D Czerucka; D Rousseau; E Berard; M Dreano; J F Peyron
Journal:  Br J Cancer       Date:  2008-01-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.